Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: Studies with an intracoronary ET(A) receptor antagonist

Circulation

Volumn 101, Issue 2, 2000, Pages 142-147

  MacCarthy, Philip A ^a   Grocott Mason, Richard ^a   Prendergast, Bernard D ^a   Shah, Ajay M ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiomyopathy; Contractility; Endothelin

Indexed keywords

AMIODARONE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; FUROSEMIDE; SIMVASTATIN; WARFARIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEART CATHETERIZATION; HEART DILATATION; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HUMAN; INOTROPISM; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0033965490     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.2.142     Document Type: Article

References (36)

1. Yanagisawa M, Kurihara H, Kimura S, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Gray GA, Webb DJ. The endothelin system and its potential as a therapeutic target in cardiovascular disease. Pharmacol Ther. 1996;72: 109-148.
3. Ponicke K, Vogelsang M, Heinroth M, Becker K, Zolk O, Bohm M, Zerkowski HR, Brodde OE. Endothelin receptors in the failing and nonfailing human heart. Circulation, 1998;97:744-751.
4. Evans HG, Lewis MJ, Shah AM. Modulation of myocardial relaxation by basal release of endothelin from endocardial endothelium. Cardiovasc Res. 1994;28:1694-1699.
5. Prendergast BD, Anning PB, Lewis MJ, Shah AM. Regulation of left ventricular relaxation in the isolated guinea-pig heart by endogenous endothelin. Cardiovasc Res. 1997;33:131-138.
6. McClellan G, Weisberg A, Winegrad S. Endothelin regulation of cardiac contractility in the absence of added endothelin. Am J Physiol. 1995;268: H1621-H1627.
7. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 1994;344:852-854.
8. Haynes WG, Ferro CJ, O'Kane KP, Somerville D, Lomax CC, Webb DJ. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation. 1996;93: 1860-1870.
9. Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet. 1995;346:732-736.
10. A receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation. 1996;94:2131-2137.
11. Sakai S, Miyauchi T, Sakurai T, Yamaguchi I, Kobayashi M, Goto K, Sugishita Y. Pulmonary hypertension caused by congestive heart failure is ameliorated by long term application of an endothelin receptor antagonist. J Am Coll Cardiol. 1996;28:1580-1588.
12. Mulder P, Richard V, Derumeaux G, Hogie M, Henry JP, Lallemand F, Compagnon P, Mace B, Comoy E, Letac B, Thuillez C. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics and cardiac remodelling. Circulation. 1997;96:1976-1982.
13. Spinale FG, Walker JD, Mukherjee R, Iannini JP, Keever AT, Gallagher KP. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Circulation. 1997;95:1918-1929.
14. Hiroe M, Hirata Y, Fujita N, Umezawa S, ItO H, Tsujino M, Koike A, Nogami A, Takamoto T, Marumo F. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy. Am J Cardiol. 1991;68:759-761.
15. McMurray JJ, Ray SG, Abdullah I, Dargie HD, Morton JJ. Plasma endothelin in chronic heart failure. Circulation. 1992;85:1374-1379.
16. Wei C-M, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, Heublein DM, Kao PC, Edwards WD, Burnett JC Jr. Endothelin in human congestive heart failure. Circulation. 1994;89:1580-1586.
17. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature. 1996;384:353-355.
18. Iwanaga Y, Kihara Y, Hasegawa K, Inagaki K, Yoneda T, Kaburagi S, Araki M, Sasayama S. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation. 1998;98:2065-2073.
19. Thomas PB, Liu ECK, Webb ML, Mukherjee R, Hebbar L, Spinale FG. Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am J Physiol. 1996;271: H2629-H2637.
20. Kelso EJ, Geraghty RF, McDermott BJ, Trimble ER, Nicholls DP, Silke B. Mechanical effects of ET-1 in cardiomyocytes isolated from normal and heart-failed rabbits. Mol Cell Biochem. 1996;157:149-155.
21. Shimoyama H, Sabbah HN, Borzak S, Tanimura M, Shevlyagin S, Scicli G, Goldstein S. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure. Circulation. 1996;94: 779-784.
22. Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, Webb DJ. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation. 1998;97:752-756.
23. Peter MG, Davenport AP. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Br J Pharmacol. 1996;117: 455-462.
24. A receptor. Life Sci. 1992;50:247-255.
25. Mahler F, Ross J Jr, O'Rourke RA, Covell JW. Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog. Am J Cardiol. 1975;35: 626-634.
26. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation. 1994;89:2070-2078.
27. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem. 1991;267:16066-16068.
28. Kass DA, Maughan WL, Guo ZM, Kono A, Sunagawa K, Sagawa K. Comparative influence of load versus inotropic state on indexes of ventricular contractility: experimental and theoretical analyses based on pressure-volume relations. Circulation. 1987;76:1422-1436.
29. Pieske B, Beyermann B, Breu V, Löffler BM, Schlotthauer K, Maier LS, Schmidt-Schweda S, Just H, Hasenfuss G. Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation. 1999;99:1802-1809.
30. Sugden PH, Bogoyevitch MA. Endothelin-1 dependent signaling pathways in myocardium. Trends Cardiovasc Med. 1996;6:87-94.
31. Shah AM. Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res. 1996;31:847-867.
32. Hilal-Dandan R, Merck ST, Lujan JP, Brunton LL. Coupling of the type A endothelin receptor to multiple responses in adult rat cardiomyocytes. Mol Pharmacol. 1994;45:1183-1190.
33. Brodde O-E, Michel MC, Zerkowski H-R. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc Res. 1995;30:570-584.
34. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation. 1994;89:2070-2078.
35. Recchia FA, McConnell PI, Bernstein RD, Vogel TR, Xu X, Hintze TH. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res. 1998;83:969-979.
36. A receptors. J Biol Chem. 1995;270:10855-10860.